Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...
Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...
Vertex Pharmaceuticals’ triple combination cystic fibrosis (CF) treatment has been approved by the Medicines and Healthcare ...
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
MoneyWeek on MSN5d
Vertex Pharmaceuticals is an uncommon opportunity in rare diseasesVertex Pharmaceuticals operates in a profitable subsector and is poised for further success ...
Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...
Well thanks very much, everyone, for joining us for our next session with Vertex. My name is Dave ... the number of variables in the first clinical trial that approach to immunosuppression had ...
and Vertex Pharmaceuticals fits this criterion perfectly. VRTX has a robust clinical pipeline of investigational therapies and continues to advance clinical and research programs. Longer term ...
Every year, amid Women’s History Month, March 8 marks International Women’s Day—a day dedicated to both honoring past efforts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback